719 filings
Page 2 of 36
8-K
irru 12rbzz2db
25 Jul 23
Second quarter revenue $2,456 million; GAAP diluted EPS $4.07; Non-GAAP diluted EPS $4.02
7:03am
8-K
l6ouapjtfaer
29 Jun 23
Submission of Matters to a Vote of Security Holders
4:24pm
DEFA14A
i3k3zhye8q3wz9tyc
13 Jun 23
Additional proxy soliciting materials
7:28am
DEFR14A
j92qz6tpf4
13 Jun 23
Revised proxy
7:25am
DEFA14A
2miwanbb9006wnkzdrh
12 Jun 23
Additional proxy soliciting materials
5:18pm
8-K
dfm75cf2vhk4eu ds
3 May 23
Other Events
9:02am
DEFA14A
aacz3mik0x0zq
28 Apr 23
Additional proxy soliciting materials
5:23pm
ARS
iwv tf1fszj2t2pg
28 Apr 23
Annual report to shareholders
5:17pm
8-K
xu6be5s6ga
25 Apr 23
Company reports first quarter 2023 results and reaffirms full year 2023 guidance
7:02am
8-K
qlfh9bfo6b8atgm hdrp
18 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:48pm
8-K
8pz9sly
8 Mar 23
Departure of Directors or Certain Officers
9:34pm
8-K
bdoqm
15 Feb 23
Biogen advances significant potential growth drivers; Company reports full year 2022 results and provides full year 2023 guidance
7:03am
8-K
if5tnr a0
10 Nov 22
Biogen Names Christopher Viehbacher President and Chief Executive Officer
7:26am
8-K
jz01q
25 Oct 22
Biogen Reports Third Quarter 2022 Results
7:08am
8-K/A
olui a4dnv0
20 Jul 22
Biogen Reports Second Quarter 2022 Results
3:08pm